Theranostics in Cancer Management: Integrating Diagnostics and Therapeutic Strategies introduces a transformative paradigm in clinical oncology, heralding a new era of precision and personalized cancer care. This comprehensive guide empowers clinicians by seamlessly integrating advanced diagnostics with targeted therapeutic approaches. The book provides an extensive exploration of theranostics across diverse clinical scenarios, ensuring that healthcare professionals are equipped with the knowledge to navigate the complexities of cancer management effectively. Beyond the introductory insights, the book delves into several types of cancer and the utilization of Artificial Intelligence in cancer detection tools.
Comprising 15 chapters, it offers an invaluable resource for health professionals, scientists, researchers, practitioners, and students who seek to expand their understanding in this evolving field. The emphasis on practical applications and emerging technologies makes it a timely addition to the field of oncology.
- Unfolds the current challenges and opportunities in theranostics encompasses an exploration of regulatory landscapes, economic implications, and strategies to enhance cancer management
- Bridges the gap between research and clinical practice, offering guidance to clinicians and researchers, contributing to evidence-based practice, and inspiring future research in the dynamic field of theranostics in oncology
- Provides a valuable guide for professionals navigating the complex and transformative journey of integrated diagnostics and therapeutic strategies in cancer management
Dr. Kuttiappan Anitha is working as Assistant Professor in School of Pharmacy and Technology Management (SPTM), SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur. She has broad teaching and research experience. Dr. Anitha is recipient of “Excellence in Academic Award” 2022 from International School of Technology and Sciences Affiliated from Govt. of India. She has guided more than 45 M.Pharm students and more than 10 batches of UG Projects. She has more than 30 publications in both national and international journals. Her area of expertise includes Immunooncology, endocrine areas, Gut Microbiota, infectious Diseases. She has also written several books and many book chapters. She has organized Conferences/seminars at university levels.
Dr. Shvetank Bhatt is an accomplished Associate Professor in the School of Health Sciences and Technology at Dr. Vishwanath Karad MIT World Peace University, located in Pune, Maharashtra, India. He holds an M. Pharm degree in Pharmacology from Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka, and a Ph.D. in Neuropharmacology from Birla Institute of Technology & Science (BITS) Pilani, Pilani Campus, Rajasthan. With many years of industrial and academic research experience, Dr. Bhatt specializes in CNS disorders, pain, inflammation, and immuno-oncology. He has received numerous accolades, including the Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award for Best Paper in Pharmacology-IJPER in 2012 and 2014. Dr. Bhatt has published dozens of papers in various national and international journals. Dr. Bhatt is a life member of the Association of Pharmaceutical Teachers of India (APTI) and the Indian Pharmacological Society (IPS).
Dr. Santenna Chenchula has been an academic faculty member and researcher in the Department of Pharmacology at the All India Institute of Medical Sciences (AIIMS) Bhopal. His research interests span across clinical pharmacology, with a focus on molecular medicine, precision medicine, pharmacogenomics, oncology, rational drug use, antimicrobial resistance, vaccines, drug discovery, clinical trials, and pharmacovigilance. He serves as a reviewer for several national and international journals in the field of biomedical research. To date, he has published dozens of articles in international and national journals and has authored several books as the corresponding first author. He is an active member of the Pharmacogenomics Research Network (PGRN), The American Society for Clinical Pharmacology and Therapeutics (ASCPT), and the Global Center for Evidence Synthesis (GCES). Currently, he is pursuing a PhD in clinical pharmacology, specializing in Precision Medicine and Pharmacogenomics.
